EISAI TO PRESENT LATEST DATA ON LEMBOREXANT AT THE 36TH ANNUAL SLEEP 2022 MEETING ...Middle East

NUTLEY, N.J., June 2, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today a total of seven poster presentations including the latest data on its in-house discovered orexin receptor antagonist lemborexant (product name: DAYVIGO® CIV) will...

Hence then, the article about eisai to present latest data on lemborexant at the 36th annual sleep 2022 meeting was published today ( Friday 03/06/2022 - 02:36 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( EISAI TO PRESENT LATEST DATA ON LEMBOREXANT AT THE 36TH ANNUAL SLEEP 2022 MEETING )

Also on site :

• Macy’s Valley Fair shoppers thwart Rolex watch thieves
• RCB-W vs UPW-W Dream11 Prediction, Dream11 Playing XI, Today Match 5, WPL 2026
• Motional puts AI at center of robotaxi reboot as it targets 2026 for driverless service